CVE-2019-18248

MEDIUMCVSS 4.3/10EPSS 0.35%

Last modified

CVE-2019-18248 is a medium-severity vulnerability rated 4.3/10 on the CVSS scale. BIOTRONIK CardioMessenger II, The affected products transmit credentials in clear-text prior to switching to an encrypted communication channel. An attacker can disclose the product’s client credentials for connecting to the BIOTRONIK Remote Communication infrastructure.. EPSS estimates a 0.35% chance of exploitation in the next 30 days.

Description

BIOTRONIK CardioMessenger II, The affected products transmit credentials in clear-text prior to switching to an encrypted communication channel. An attacker can disclose the product’s client credentials for connecting to the BIOTRONIK Remote Communication infrastructure.

Metrics

CVSS 3.1
4.3/10

CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

EPSS Probability
0.35%

27.0th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
BiotronikCardiomessenger Ii-S Gsm Firmware2.20
BiotronikCardiomessenger Ii-S T-Line Firmware2.20

References

Timeline

Published
Last Modified
Status
Modified

Frequently Asked Questions

What is CVE-2019-18248?
BIOTRONIK CardioMessenger II, The affected products transmit credentials in clear-text prior to switching to an encrypted communication channel. An attacker can disclose the product’s client credentials for connecting to the BIOTRONIK Remote Communication infrastructure.
How severe is CVE-2019-18248?
CVE-2019-18248 has a CVSS score of 4.3/10 (MEDIUM severity). The EPSS model estimates a 0.35% probability of exploitation in the next 30 days.
How do I fix CVE-2019-18248?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2019-18248?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST